CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | Daly James M Director | Grant or award · Director Stock Options (Right to Buy) | +11,045 | 11,045 | ||
| 2023-06-01 | Daly James M Director | Grant or award · Restricted Stock Units | +6,652 | 6,652 | ||
| 2023-06-01 | GAROFALO ELIZABETH A. Director | Option exercise | +8,552 | 18,780 | ||
| 2023-06-01 | GAROFALO ELIZABETH A. Director | Option exercise · Restricted Stock Units | −8,552 | 0 | ||
| 2023-06-01 | GAROFALO ELIZABETH A. Director | Grant or award · Director Stock Options (Right to Buy) | +11,045 | 11,045 | ||
| 2023-06-01 | GAROFALO ELIZABETH A. Director | Grant or award · Restricted Stock Units | +6,652 | 6,652 | ||
| 2023-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award | +13,304 | 3,623,747 | ||
| 2023-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award | +13,304 | 39,330,977 | ||
| 2023-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | −22,090 | 22,090 | ||
| 2023-05-24 | BAKER BROS. ADVISORS LP Director | Purchase | +20,304 | $25.27 | $513K | 3,583,642 |
| 2023-05-24 | BAKER BROS. ADVISORS LP Director | Purchase | +218,171 | $25.27 | $5.5M | 39,029,686 |
| 2023-05-24 | BAKER BROS. ADVISORS LP Director | Purchase | +2,688 | $25.51 | $69K | 3,586,330 |
| 2023-05-24 | BAKER BROS. ADVISORS LP Director | Purchase | +28,878 | $25.51 | $737K | 39,058,564 |
| 2023-05-24 | BAKER BROS. ADVISORS LP Director | Purchase | +24,113 | $25.65 | $618K | 3,610,443 |
| 2023-05-24 | BAKER BROS. ADVISORS LP Director | Purchase | +259,109 | $25.65 | $6.6M | 39,317,673 |
| 2023-05-23 | BAKER BROS. ADVISORS LP Director | Option exercise | +12,500 | $17.01 | $213K | 3,545,539 |
| 2023-05-23 | BAKER BROS. ADVISORS LP Director | Option exercise | +12,500 | $17.01 | $213K | 38,620,261 |
| 2023-05-23 | BAKER BROS. ADVISORS LP Director | Purchase | +10,858 | $25.33 | $275K | 3,556,397 |
| 2023-05-23 | BAKER BROS. ADVISORS LP Director | Purchase | +116,672 | $25.33 | $3.0M | 38,736,933 |
| 2023-05-23 | BAKER BROS. ADVISORS LP Director | Purchase | +6,941 | $25.54 | $177K | 3,563,338 |
Page 19 of 63 · 1,260 trades